Anti-Hu beta2-Microglobulin PerCP-Cy™5.5

*Poláková K, Železníková T, Russ G: HLA-G5 in the blood of leukemia patients and healthy individuals. Leuk Res. 2013 Feb;37 (2) :139-45., URL: https://pubmed.ncbi.nlm.nih.gov/23146557/, *Lafon M, Prehaud C, Megret F, Lafage M, Mouillot G, Roa M, Moreau P, Rouas-Freiss N, Carosella ED: Modulation of HLA-G Expression in Human Neural Cells after Neurotropic Viral Infections. J Virol. 2005 Dec; 79 (24) : 15226-15237., URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13160, *Khurana M, Traum AZ, Aivado M, Wells MP, Guerrero M, Grall F, Libermann TA, Schachter AD: Urine proteomic profiling of pediatric nephrotic syndrome. Pediatr Nephrol. 2006 Sep;21 (9) :1257-65. Epub 2006 Jun 30., URL: https://www.ncbi.nlm.nih.gov/pubmed/16810512?dopt=, *Hilgert I, Horejsi V, Kristofova H: The use of murine monoclonal antibody B2M-01 for detection and purification of human beta 2-microglobulin. Folia Biol (Praha) . 1984;30 (6) :369-76., URL: https://www.ncbi.nlm.nih.gov/pubmed/6394369?dopt=A, *Polakova K, Karpatova M, Russ G: Dissociation of beta 2-microglobulin is responsible for selective reduction of HLA class I antigenicity following acid treatment of cells. Mol Immunol. 1993 Oct;30 (14) :1223-30., URL: https://pubmed.ncbi.nlm.nih.gov/7692238/